Adam Feuerstein, senior biotech analyst at TheStreet, tweeted from the Alexza Pharmaceutical/FDA conference for its ADASUVE drug, stating that the FDA is "painting a grimmer safety picture...".
Hinting that the approval might not go through.
Shares of Alexza Pharmaceuticals ALXA are currently halted.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in